These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16996843)

  • 1. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study.
    Staudt A; Hummel A; Ruppert J; Dörr M; Trimpert C; Birkenmeier K; Krieg T; Staudt Y; Felix SB
    Am Heart J; 2006 Oct; 152(4):712.e1-6. PubMed ID: 16996843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
    Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
    J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.
    Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G
    J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB
    J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
    Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB
    Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
    Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
    Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
    Herda LR; Trimpert C; Nauke U; Landsberger M; Hummel A; Beug D; Kieback A; Dörr M; Empen K; Knebel F; Ewert R; Angelow A; Hoffmann W; Felix SB; Staudt A
    Am Heart J; 2010 May; 159(5):809-16. PubMed ID: 20435190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
    Ohlow MA; Brunelli M; Schreiber M; Lauer B
    J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.
    Knebel F; Böhm M; Staudt A; Borges AC; Tepper M; Jochmann N; Wernicke KD; Felix S; Baumann G
    Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadsorption in dilated cardiomyopathy.
    Dörffel WV; Wallukat G; Baumann G; Felix SB
    Ther Apher; 2000 Jun; 4(3):235-8. PubMed ID: 10910026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.
    Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H
    J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy.
    Dörffel WV; Felix SB; Wallukat G; Brehme S; Bestvater K; Hofmann T; Kleber FX; Baumann G; Reinke P
    Circulation; 1997 Apr; 95(8):1994-7. PubMed ID: 9133505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
    Bulut D; Creutzenberg G; Mügge A
    Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
    Felix SB; Staudt A; Landsberger M; Grosse Y; Stangl V; Spielhagen T; Wallukat G; Wernecke KD; Baumann G; Stangl K
    J Am Coll Cardiol; 2002 Feb; 39(4):646-52. PubMed ID: 11849864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up.
    Dörffel WV; Wallukat G; Dörffel Y; Felix SB; Baumann G
    Int J Cardiol; 2004 Dec; 97(3):529-34. PubMed ID: 15561344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution.
    Staudt A; Schäper F; Stangl V; Plagemann A; Böhm M; Merkel K; Wallukat G; Wernecke KD; Stangl K; Baumann G; Felix SB
    Circulation; 2001 Jun; 103(22):2681-6. PubMed ID: 11390337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.